Please ensure Javascript is enabled for purposes of website accessibility

Pharmos Announces Reverse Split of Common Stock

Pharmos (NasdaqSC: PARSD), an Iselin developer of novel therapeutics to treat a range of indiPharmos (NasdaqSC: PARSD), an Iselin developer of novel therapeutics to treat a range of indi

NJBIZ STAFF
Write to the Editorial Department at editorial@njbiz.com.